GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (OTCPK:WXXWY) » Definitions » Inventories, Raw Materials & Components

WXXWY (WuXi Biologics (Cayman)) Inventories, Raw Materials & Components : $268 Mil (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is WuXi Biologics (Cayman) Inventories, Raw Materials & Components?

WuXi Biologics (Cayman)'s inventories, raw materials & components for the quarter that ended in Jun. 2024 was $268 Mil.

WuXi Biologics (Cayman)'s quarterly raw materials declined from Jun. 2023 ($270 Mil) to Dec. 2023 ($244 Mil) but then increased from Dec. 2023 ($244 Mil) to Jun. 2024 ($268 Mil).

WuXi Biologics (Cayman)'s annual raw materials increased from Dec. 2021 ($261 Mil) to Dec. 2022 ($323 Mil) but then declined from Dec. 2022 ($323 Mil) to Dec. 2023 ($244 Mil).

WuXi Biologics (Cayman) Inventories, Raw Materials & Components Historical Data

The historical data trend for WuXi Biologics (Cayman)'s Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi Biologics (Cayman) Inventories, Raw Materials & Components Chart

WuXi Biologics (Cayman) Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 162.13 261.15 322.82 243.74 -

WuXi Biologics (Cayman) Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 322.82 269.78 243.74 268.17 -

WuXi Biologics (Cayman) Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

WuXi Biologics (Cayman) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (OTCPK:WXXWY) » Definitions » Inventories, Raw Materials & Components
Comparable Companies
HKSE:01801 HKSE:09926 HKSE:01177 HKSE:06990 HKSE:01877 HKSE:09995 HKSE:01530 HKSE:01548 HKSE:02696 HKSE:09969 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
WXIBF:USA 02269:Hong Kong 1FW2:Germany
Address
No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092
Website
https://www.wuxibiologics.com
WuXi Biologics is one of the largest global biologic global contract development and manufacturing organizations. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 18.7 billion. North America represented 57.3% of total revenue in 2024. The firm has a "follow and win the molecule" strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual sourcing strategy by providing drug products and drug substance manufacturing.